InsiderClue
← All stocks

Telix Pharmaceuticals Ltd

TLX Net buying
CIK 0002007191 #1496 in the set updated 17 Sep 2026
Bought (12 mo)
$1.02M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$1.02M
+$1.02M against sales at will

By person

2 insiders · 3 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Behrenbruch Christian
MD & Group CEO
$996.74K (2)
—
+$996.74K
20,742,935
6.12%
$200.29M
+0.3%
Smith Darren Charlton
Group Chief Financial Officer
$20.00K (1)
—
+$20.00K
13,992
0.0041%
$135.11K
+29.4%

Individual transactions

3
Insider
Date
Role
Action
Shares
Price
Amount
Smith Darren Charlton
7 Sep 2026
Group Chief Financial Officer
Buy
2,071
$9.66
$20.00K
Behrenbruch Christian
29 Apr 2026
MD & Group CEO
Buy indirect
33,435
$14.87
$497.18K
Behrenbruch Christian
28 Apr 2026
MD & Group CEO
Buy indirect
34,500
$14.48
$499.56K
Show all 3 transactions →

What was left out

Form 4 filings counted 3
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 1,111
History held since 1 Apr 2026